Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human IL-6 ELISA Kit (AC3818)
Cat.#: ASET-2407
Specifications
Description Human IL-6 ELISA Kit allows for the in vitro quantitative determination of human IL-6 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 2.813 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 4.688-300 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1402 Human Nicotinic Acetylcholine Receptor alpha 7 ELISA Kit (AC2813) Quantitative inquiry ASET-1728 Porcine iNOS ELISA Kit (AC3139) Quantitative inquiry ASET-1646 Chicken IL-6 ELISA Kit (AC3057) Quantitative inquiry ASET-2541 Human CD133 ELISA Kit (AC3952) Quantitative inquiry ASET-2310 Human C1QB ELISA Kit (AC3721) Quantitative inquiry ASET-1670 Human Histidine Decarboxylase ELISA Kit (AC3081) Quantitative inquiry ASET-2272 Mouse SNAP25 ELISA Kit (AC3683) Quantitative inquiry ASET-2120 Rat ARNT2 ELISA Kit (AC3531) Quantitative inquiry ASET-1409 Rat SLC26A4 ELISA Kit (AC2820) Quantitative inquiry ASET-1745 Canine IL-6 ELISA Kit (AC3156) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket